Apelin and nutritional status in children on dialysis

References

• KDOQI Work Group. KDOQI Clinical Practice Guidelines for Nutrition in children with CKD: 2008 update. Executive summary. Am J Kidney Dis. 2009;53(Suppl 2):S11–S104
   Google Scholar
• Mak RH, Cheung WW, Zhan JY, Shen Q, Foster BJ. Cachexia and protein-energy wasting in children with chronic kidney disease. Pediatr Nephrol. 2012;27:173–181
   Google Scholar
• Sylvestre LC, Fonseca KPD, Stinghen AEM, Pereira AM, Meneses RP, Pecoits-Filho R. The malnutrition and inflammation axis in pediatric patients with chronic kidney disease. Pediatr Nephrol. 2007;22:864–873
   Google Scholar
• Kuhlmann MK, Levin NW. How common is malnutrition in ESRD? New approaches to diagnosis of malnutrition. Blood Purif. 2008;26:49–53
   Google Scholar
• Bonanni A, Mannucci I, Verzola D, Saffioti S, Gianetta E, Garibotto G. Protein-energy wasting and mortality in chronic kidney disease. Int J Environ Res Public Health. 2011;8:1631–1654
   PubMedGoogle Scholar
• Wosniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: The new endocrine organ? A review article. Dig Dis Sci. 2008;54:1847–1856
   Google Scholar
• Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115:911–919
   PubMed Web of Science ®Google Scholar
• Axelsson J, Stenvinkel P. Role of fat mass and adipokines in chronic kidney disease. Curr Opin Nephrol Hypertens. 2008;17:25–31
   PubMed Web of Science ®Google Scholar
• Manolescu B, Stoian I, Atanasiu V, Busu C, Lupescu O. Review article: The role of adipose tissue in uremia-related insulin resistance. Nephrology. 2008;13:622–628
   Google Scholar
• Castan-Laurell I, Boucher J, Dray C, Daviaud D, Guigné C, Valet P. Apelin, a novel adipokine over-produced in obesity: Friend or foe? Mol cell Endocrinol. 2005;245:7–9
   PubMed Web of Science ®Google Scholar
• Kleinz MJ, Davenport AP. Emerging roles of apelin in biology and medicine. Pharmacol Ther. 2005;107:198–211
   PubMed Web of Science ®Google Scholar
• Vhandrasekaran B, Dar O, McDonagh T. The role of apelin incardiovascular function and heart failure. Eur J Heart Fail. 2010;10(8):725–732
   Google Scholar
• Laderidas-Lopes R, Ferreira-Martins J, Leite-Moreira AF. The apelinergic system: The role played in human physiology and pathology and potential therapeutic applications. Arq Bras Cardiol. 2008;90:343–349
   Google Scholar
• Xu S, Tsao PS, Yue P. Apelin and insulin resistance: Another arrow for the quiver? J Diabetes. 2011;3:225–231
   PubMed Web of Science ®Google Scholar
• Daviaud D, Boucher J, Gesta S, et al. TNFalfa up-regulates apelin expression in human and mouse adipose tissue. FASEB J. 2006;20:1528–1530
   PubMed Web of Science ®Google Scholar
• Malyszko J, Malyszko JS, Pawlak K, Wolczynski S, Mysliwiec M. Apelin, a novel adipocytokine, in relation to endothelial function and inflammation in kidney allograft recipients. Transplant Proc. 2008;40:3466–3469
   PubMedGoogle Scholar
• Yu S, Zhang Y, Li MZ, et al. Chemerin and apelin are positively correlated with inflammation in obese type 2 diabetic patients. Chin Med J (Engl). 2012;125:3440–3444
   PubMed Web of Science ®Google Scholar
• El-Shehaby AM, El-Khatib MM, Battah AA, Roshdy AR. Apelin: A potential link between inflammation and cardiovascular disease in end stage renal disease patients. Scand J Clin Lab Invest. 2010;70:421–427
   PubMed Web of Science ®Google Scholar
• Neyzi O, Andrzej F, Bundak R, Gunoz H, Draendeliler F, Bas F. Growth references for Turkish children aged 6–18 years. Acta Pediatr. 2006;95:1635–1641
   PubMed Web of Science ®Google Scholar
• Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O. Body mass index references for Turkish children. Acta Pediatr. 2006;95:194–198
   PubMed Web of Science ®Google Scholar
• Paglialonga F, Edefonti A. Nutrition assessment in children on peritoneal dialysis. Pediatr Nephrol. 2009;24:721–730
   Google Scholar
• Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr. 1982;34:2540–2545
   Google Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–576
   PubMed Web of Science ®Google Scholar
• Srivaths PR, Wong C, Goldstein SL. Nutrition aspects in children receiving maintenance hemodialysis: Impact on outcome. Pediatr Nephrol. 2009;24:951–957
   Google Scholar
• Mendley SR, Majkowski NL. Urea and nitrogen excretion in pediatric peritoneal dialysis patients. Kidney Int. 2000;58:2564–2570
   Google Scholar
• Malyszko J, Malyszko JS, Koźminski P, Myśliwiec M. Apelin and cardiac function in hemodialyzed patients: Possible relations? Am J Nephrol. 2006;26:121–126
   PubMed Web of Science ®Google Scholar
• Codognotto M, Piccoli A, Zaninotto M, Vertolli U, Tona F, Boffa GM. Evidence for decreased circulating apelin beyond heart involvement in uremic cardiomyopathy. Am J Nephrol. 2007;27:1–6
   PubMed Web of Science ®Google Scholar
• Leal VO, Lobo JC, Stockler-Pinto MB, Farage NE, et al. Apelin: A peptide involved in cardiovascular risk in hemodialysis patients? Ren Fail. 2012;34:577–581
   PubMed Web of Science ®Google Scholar
• Mafra D, Lobo JC, Farage NE, et al. The relationship between apelin and parathyroid hormone in hemodiaysis patients. Ren Fail. 2012;34:970–973
   PubMed Web of Science ®Google Scholar
• Cernaro V, Lacquaniti A, Lorenzano G, et al. Apelin, plasmatic osmolality and hypotension in dialyzed patients. Blood Purif. 2012;33:317–323
   Google Scholar
• Karadag S, Ozturk S, Gursu M, et al. The relationship between apelin and cardiac parameters on peritoneal dialysis: Is there a new cardiac parameter? BMC Nephrol. 2014;15:18
   PubMedGoogle Scholar
• Boucher J, Masri B, Davidaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146:1764–1771
   PubMed Web of Science ®Google Scholar
• Charles CJ. Putative role for apelin in pressure/volume homeostasis and cardiovascular disease. Cardiovasc Hematol Agents Med Chem. 2007;5:1–10
   PubMedGoogle Scholar
• Kazancioglu R, Gursu M, Karadag S, et al. Volume status in patients on peritoneal dialysis: The role of apelin and bio-impedance spectroscopy. Ren Fail. 2012;34:1068–1073
   PubMed Web of Science ®Google Scholar
• Garcia-Diaz D, Campion J, Milagro FI, Martinez JA. Adiposity dependent apelin gene expression: Relationships with oxidative and inflammation markers. Mol Cell Biochem. 2007;305:87–94
   PubMed Web of Science ®Google Scholar
• Yue P, Jin H, Xu S, et al. Apelin decreases lipolyses via G(q), G(i), and AMPK-Dependent mechanisms. Endocrinology. 2011;152:59–68
   PubMed Web of Science ®Google Scholar
• Than A, Cheng Y, Foh LC, et al. Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways. Mol Cell Endocrinol. 2012;15:227–241
   Google Scholar
• Malyszko J, Kozminski P, Malyszko J, Mysliwiec M. Type of arteriovenous fistule, NHYA class and apelin in hemodialyzed patients. Int Urol Nephrol. 2011;43:185–190
   PubMed Web of Science ®Google Scholar
• Lv D, Li H, Chen L. Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis. Acta Biochim Biophys Sin. 2013;45:527–533
   Google Scholar
• Kadoglou NP, Sailer N, Moumtzouoglou A, Gerasimidis T, Kostakis A, Liapis CD. Adipokines: a novel link between adioposity and carotid plaque vulnerability. Eur J Clin Invest. 2012;42:1278–1286
   PubMed Web of Science ®Google Scholar
• Taşcı I. Apelin, prediabetes and atherosclerosis. Exp Clin Endocrinol Diabetes. 2011;119:457–458
   Google Scholar